SHG:603367 - Cisen Pharmaceutical Co Ltd

Cisen Pharmaceutical Co Ltd
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2015 Q2	2015 Q4	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	957.85M 9.6%	925.61M -3.4%	1.03B 10.8%	869.77M -15.2%	993.69M 14.2%	1.05B 5.5%	1.15B 10.1%	1.13B -1.7%	1.09B -4.3%	990.15M -8.8%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	416.58M 17.5%	411.92M -1.1%	501.77M 21.8%	392.97M -21.7%	447.19M 13.8%	425.85M -4.8%	523.28M 22.9%	420.95M -19.6%	569.32M 35.2%	388.42M -31.8%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	541.27M 4.2%	513.69M -5.1%	523.66M 1.9%	476.8M -8.9%	546.5M 14.6%	622.52M 13.9%	630.97M 1.4%	713.46M 13.1%	515.99M -27.7%	601.72M 16.6%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	872.55M 13.5%	867.8M -0.5%	987.17M 13.8%	765.83M -22.4%	909.78M 18.8%	942.17M 3.6%	1.09B 15.7%	970.28M -11.0%	975.81M 0.6%	863.49M -11.5%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	455.98M 10.1%	455.88M 0.0%	485.41M 6.5%	372.86M -23.2%	462.59M 24.1%	516.32M 11.6%	567.16M 9.8%	549.33M -3.1%	406.49M -26.0%	475.07M 16.9%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	85.29M -18.8%	57.82M -32.2%	38.26M -33.8%	103.94M 171.7%	83.92M -19.3%	106.21M 26.6%	63.81M -39.9%	164.12M 157.2%	109.5M -33.3%	126.66M 15.7%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	182.6M -	-	-	-	183.76M -	-	-	-	266.89M -	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	74.01M -31.9%	102.81M 38.9%	48.65M -52.7%	96.75M 98.9%	87.3M -9.8%	108.28M 24.0%	57.74M -46.7%	155.85M 169.9%	108.3M -30.5%	126.29M 16.6%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.16 -33.3%	0.23 43.8%	0.11 -52.2%	0.21 90.9%	0.2 -4.8%	0.23 15%	0.13 -43.5%	0.34 161.5%	0.24 -29.4%	0.28 16.7%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.16 -33.3%	0.23 43.8%	0.11 -52.2%	0.21 90.9%	0.2 -4.8%	0.23 15%	0.13 -43.5%	0.34 161.5%	0.24 -29.4%	0.28 16.7%